Importance Two 2013 systematic reviews to inform the US Preventive Services Task Force
(USPSTF) found insufficient evidence to assess benefits and harms of screening for primary …

Background: Recent studies on the PRESERFLO MicroShunt suggest that it may be effective
in lowering intraocular pressure (IOP); however, the number of studies on this device …

PURPOSE: The LiGHT trial has shown selective laser trabeculoplasty (SLT) to be clinically
and cost-effective as a primary treatment of open-angle glaucoma (OAG) and ocular …

Purpose To compare visual field outcomes of ocular hypertensive and glaucoma patients
treated first with medical therapy with those treated first with selective laser trabeculoplasty …

Poor adherence to topical glaucoma medications has been linked to worse visual field
outcomes in glaucoma patients. Therefore, identifying and overcoming the adherence …

Introduction Glaucoma is the leading cause of irreversible blindness worldwide. Medical
therapy is the main line of treatment of open-angle glaucoma (OAG) and ocular …

Purpose The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial has shown
selective laser trabeculoplasty (SLT) to be clinically and cost-effective as a primary treatment …

Understanding the association between ocular surface disease and glaucoma is important
for improving adherence to treatment and introducing practical solutions. While topical …

Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high
risk of lifetime blindness. Uncertainty exists about whether primary medical management …

Purpose As the landscape in ophthalmology and related commissioning continues to
change, there is a pressing need to re‐evaluate the current scope of practice of hospital …